Next Phase Newsletter

By Claire Jeong, Director of Research, Asia BD, LSN

LSN is busily preparing for our largest conference of the year, RESI San Francisco, during JPM week on Tuesday, January 14^th, 2020. In our last RESI SF conference, we had over 1,200 attendees join, making it our largest conference to date.

This time, we are featuring 3 tracks of panels and workshops that encompass a wide variety of sectors within life science and healthcare, including more specialized topics relevant to current industry trends. For the very first time, we are also dedicating an entire track for Featured Company Pitch Sessions, which will be a valuable opportunity for companies to showcase their technologies.

The ultimate goal of our panels and workshops is to provide valuable insights to fundraising early-stage companies, especially on how groups can effectively seek to work with investors and strategic partners. RESI strives to feature industry players from large VCs to new funds, from large corporations to angel investors, to lend their expertise to the entrepreneurs attending RESI. With excellent returning speakers and many new contributors, the panel lineup at this RESI is sure to be one of the best we’ve had.

For those who are already registered for RESI, we highly encourage you to attend some panels that are relevant to your company’s interests. If you’re interested in hearing from and meeting active industry experts, but haven’t registered, it’s not too late!

Without further ado, here are some of the panelists who will be joining our panels and workshops at RESI San Francisco:

Chris Haskell VP, Head Open Innovation Center – North America West Bayer	Joyce Chan Director of External R&D Amgen	Anne Wellington Managing Director Cedars-Sinai Health Accelerator	Richard Proscia Senior Associate Providence Ventures
Brent Stackhouse Managing Director Mount Sinai Ventures	Wei Wu Senior Associate Illumina Ventures	Mike Ryan Co-Founder & CEO Bullet Point Network	Brent Ahrens General Partner Canaan Partners
Christina Takke Co-Founder & Managing Partner V-Bio Ventures	Roel Bulthuis Managing Director INKEF Capital	Claudia Karnbach Head of Business Development & Licensing, Oncology Bayer	David Cruikshank Partner ARCH Venture Partners
Dani Bach Partner +ND Capital	Bill Hyun Venture Partner Genoa Ventures	Chihiro Hosoya BD/VC Head Astellas Rx+ Business Accelerator	Ronald Dorenbos Head, Innovation Management & Scouting Takeda
Nicholas Mourlas Senior Director, New Ventures Johnson & Johnson	Gerry Brunk Managing Director Lumira Ventures	Neil Swami Principal Catalyst Health Ventures	Z Haroon Chairman and General Partner Julz Co LLC
Lauren Tyra Principal Scientist Green Park & Golf Ventures	Kwame Ulmer Venture Partner Wavemaker Three-Sixty Health	Diana Saraceni Founder and Managing Partner Panakes Partners	Ted Driscoll Managing Partner DigitalDx Ventures
Noel Jee Senior Associate Illumina Ventures	Sharon Chan Head of JLABS @Shanghai Johnson & Johnson	Weiyong Sun Senior Director, Specialty Medicine Search & Evaluation, Global Business Development Daiichi Sankyo	Lu Han Director of Business Development, Asia Pacific Lumira Ventures
Yao Li Ho Senior Director of Business Development LYFE Capital	Yanghuan Bao Investment Partner BOHE Angel Fund	Michelle Gon Partner McDermott Will & Emery Shanghai Offices	David Xu Chief Business Officer Viva Biotech
Frank Yan Operating Partner 3E Bioventures	Elona Baum Managing Director DEFTA Partners	Tad Weems Managing Director, Early Stage Partnerships Agilent Technologies	Jiwon Huh Director of Corporate Strategy Boryung Holdings
Lu Zhang Founder & Managing Partner Fusion Fund	Xinhong Lim Director Vickers Venture Partners	Yizhen Dong Principal 11.2 Capital	Miraj Sanghvi Principal DigiTx Partners

By Bryanna Allison, Business Development Manager, LSN

If you’ve registered for RESI San Francisco, then it’s likely that your goal is to book a strong slate of meetings, followed by a full day of face-to-face meetings with investors at RESI.  Here is our advice for partnering success at RESI:

• Fill out your profile! This will provide investors with information above and beyond what you can fit in your intro message. If you fill out the key fields in your profile, attendees can revert back there for more information.
• Use the filters in the sidebar when searching for meeting partners! Whether you are a startup, investor or service provider, the filters are in place to make your lives easier. You can pick a category of attendees to search, then use the filters to narrow down to the most relevant fits for you, such as investors who are interested in your sector.
• Send as many relevant meeting requests as possible. Always use the “book a meeting” option for initial contact.
• Put effort into the message you are sending along with your meeting requests. Tell them what you’re doing, who you are, why you’d be a great fit to work together and what you’re looking to get out of the relationship. Keep it concise, but informative!
• Follow up on your requests. You can use the “send a message” option in RESI Partnering to send follow-up notes, or if you have the investor’s contact info you could send an email directly.
• Continue to check the platform regularly. New investors, startup and service provider attendees are added every day. If you want to focus on newly added profiles, you can change the order of search results from ‘Order alphabetically’ to ‘Order by date approved’ and look at who’s joined since your last visit.
• Join our partnering tutorials so you can see it all firsthand! Please visit our website for the complete partnering tutorial schedule.
• Bring your partnering schedule to RESI – either print it out or have it available on your phone.

Using the partnering platform effectively can help you make the most out of RESI! It’s there so you know exactly who is coming and exactly who you need to talk to. Don’t miss out on our largest event of the year and this excellent opportunity to network with over 500 life science investors.

By Candice He, Global Investment Strategist, LSN

As a co-organizer of RESI Shanghai, Enmore has become a valuable partner of Life Science Nation, utilizing their expertise in the local market and as conference organizers to make RESI a success, with more than 450 investors, startups and service providers in attendance. LSN and Enmore have a common goal of creating an international ecosystem for advancing life science technologies to market in a global economy, and will continue to partner to achieve this. For those interested in exploring the China market and establishing relationships with key players in the China life science ecosystem, we invite you to attend the Enmore Bio Conference, taking place at the Suzhou International Expo Center from February 20-22, 2020.

What is EBC?

Enmore Bio Conference (EBC) is the largest and most influential bio-industry conference in China, as well as the most open conference platform jointly created by Enmore Healthcare, the organizer, and many industry associations, institutions, companies and experts for the whole industry chain.

EBC consists of four parallel conferences: the 10^th Antibody Drugs & Novel Biological Summit, the 8^th Molecular Diagnostics Summit, the 6^th Immunotherapy Industry Summit, and the 3^rd 17TALK Healthcare Investment & Financing Leadership Forum. The four-in-one event covers topics concerning the whole industry chain of diagnosis, treatment and medication, and other topics like CDx, target development, clinical research and policy discussion will also be touched through a dozen of special forums. The Enmore Bio Exhibition, as part of this event, will attract more than 200 suppliers of instruments, consumables and services. The EBC, which combines conference and exhibition, has become a benchmark platform for high-level exchanges and cooperation in the bio-industry in China and abroad.

Conference website: http://ebc.enmorebiz.com/english.html

Why choose EBC?

EBC is committed to building China’s largest and most influential bio industry event through four parallel conferences, a dozen of co-organized forums, three invited-only meetings for CEOs and pre-event business visits. More than 150 enterprise leaders and experts will make presentations during this event.

Previous reports of EBC:

https://mp.weixin.qq.com/s/h1YQvgaOpClaYRUmNFAmdg

http://ebc2019.enmorebiz.com

Co-organizations of EBC 2020

Guangzhou KingMed Diagnostics Group Co., Ltd.

PersonGene

Wuhan Tongji Hospital

Renmin Hospital Of Wuhan University

Shanghai Junshi Biosciences Co., Ltd.

Hengrui Medcine

Innoforce Pharmaceuticals Co., Ltd.

TOT Biopharm

SAPA-China

Everbright Medical & Healthcare Fund

EBC parallel conferences:

10^th Antibody Drugs & Novel Biological Summit

The 10^th Antibody Drugs & Novel Biological Summit is co-organized by Junshi Biosciences, Hengrui Medicine, Innoforce Pharmaceuticals, TOT BIOPHARM and SAPA-China. It covers the whole process of early research and development, process development, mass production, industrialization and commercialization. We will bring together CEOs and top leaders of functional departments of local listed companies, as well as heads of R&D, production, quality, process and business of antibody enterprises at home and abroad through a platform of exchanges and cooperation for thousands of people.

8^th Molecular Diagnostics Summit

The 8^th Molecular Diagnostics Summit is co-organized by Enmore and KingMed Diagnostics. This time we focus on “molecular diagnostics market structure and corporate strategy”, “multi-platform detection technology for clinical diagnosis” and “to create competitive molecular diagnostic products”. Authoritative experts in precision medicine and outstanding enterprises such as Jiangsu Center for Clinical Laboratories, Shanghai Center for Clinical Laboratory, Berry Genomics, Geneseeq, and KingMed Diagnostics Group will participate in this summit. An invited-only CEO meeting will happen during the summit, organized by Clinical Laboratories leaders.

6^th Immunotherapy Industry Summit

The 6^th Immunotherapy Industry Summit aims to provide businesses with the industrialization of cellular immunotherapy in the next two years. The forum is jointly developed by experts and scholars in the field of cellular immunotherapy study, quality control leaders of first-tier companies, and CEOs of domestic and foreign companies with extensive industrialization experience! Companies and institutions involved include Fosun Kite Biotechnology Co., Ltd, JW Therapeutics, Cellular Biomedicine Group, PersonGene, Tongji Hospital, etc.

3^rd 17TALK Healthcare Investment & Financing Leadership Forum

The 3^rd 17TALK Healthcare Investment & Financing Leadership Forum is co-hosted by Enmore Healthcare and Everbright Medical & Healthcare Fund. The forum features healthcare investment trends and corporate listing, inviting local and international top investors to participate in the discussions. Special financing roadshows will be held to provide a financing platform for enterprises.

Who will attend EBC?

EBC 2019 attracted 2,208 attendees, and EBC 2020 is expected to exceed 3,000 attendees. The participating groups include entrepreneurs, scientists, clinicians, investors and suppliers, mostly CEOs and heads of R&D, production, quality, process and commercialization.

Part of EBC 2019 attendees

Conference Agenda of EBC 2020

Registration at EBC

Online registration:https://ienmore.com/enmoreweb/pc/index.html?language=1&activityId=1267

Consultation: healthcare@enmore.com